Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 2Recurrence 1Ovarian Neoplasms 1Neoplasms, Unknown Primary 1Liver Neoplasms 1Congenital Abnormalities 1Colonic Neoplasms 1

Interventions

Cytarabine 86fludarabine phosphate 85Peripheral Blood Stem Cell Transplantation 76Cyclophosphamide 69Busulfan 63Mycophenolic Acid 51Tacrolimus 48Cyclosporine 48Etoposide 43Whole-Body Irradiation 42Antilymphocyte Serum 40Methotrexate 39Filgrastim 39Flow Cytometry 30Radiotherapy 29Melphalan 24Mitoxantrone 23Daunorubicin 23Idarubicin 21Cord Blood Stem Cell Transplantation 19Polymerase Chain Reaction 17Methylprednisolone 17Gene Expression Profiling 17sargramostim 15Granulocyte Colony-Stimulating Factor 15Clofarabine 15Transplantation 14Decitabine 14Gemtuzumab 13aldesleukin 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Congenital Abnormalities × Whole Genome Sequencing × Clear all
NCT05071859 2026-02-06

Genetic Overlap Between Anomalies and Cancer in Kids in the Children's Oncology Group: The COG GOBACK Study

Children's Oncology Group

Active not recruiting
1,000 enrolled

Congenital Abnormalities, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡